Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need

July 2024

What does the approval for human use of new gene editing techniques mean for patients?

Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need

July 2024

This article reports on the development of gene therapy treatment for sickle cell and thalassaemia.

Also of interest

RCPath response to the UK NSC Consultation on screening of neonates and adults for thrombophilia
Published: April 2017
Published: April 2017
An audit of compliance with the British Society for Haematology (BSH) guideline for platelet transfusions in adult patients
Published: August 2017
Published: August 2017
An audit of compliance with the British Society for Haematology guideline on laboratory diagnosis of malaria.docx
Published: May 2022
Published: May 2022
Intercollegiate Committee on Haematology Mtg Minutes - Dec 2015
Published: February 2017
Published: February 2017
An audit of compliance with the BCSH guideline on the first line management of classical Hodgkin lymphoma (cHL)
Published: April 2016
Published: April 2016

More resources